Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rongjuan Dai"'
Publikováno v:
Epigenetics, Vol 18, Iss 1 (2023)
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disorders worldwide. The mitophagy is suggested to be repressed in NAFLD, but the mechanism remains to be elucidated. Methods: NAFLD cell and mouse models were establishe
Externí odkaz:
https://doaj.org/article/22cb7b9d79444cb5a42e22dcb4401a15
Publikováno v:
Immunity, Inflammation and Disease, Vol 11, Iss 9, Pp n/a-n/a (2023)
Abstract Background Coronavirus disease‐19 (COVID‐19) is a zoonotic disease that has become a global pandemic. The fast evolution of the COVID‐19 pandemic and persist problems make COVID‐19 highly infectious; publicly accessible literature an
Externí odkaz:
https://doaj.org/article/85ddd5b1aa19457aa06ab4c8c0c33019
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Background. The coronavirus disease 2019 (COVID-19) has outbroken into a global pandemic. The death rate for hospital patients varied between 11% and 15%. Although COVID-19 is extremely contagious and has a high fatality rate, the amount of knowledge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edf4b903b8a3b2197b3387b024863d8
https://pubmed.ncbi.nlm.nih.gov/36248407
https://pubmed.ncbi.nlm.nih.gov/36248407
Autor:
Yi Tian, Guozhong Gong, Min Zhang, Yun Xu, Mingming Li, Feng Peng, Yongfang Jiang, Yue Luo, Xinqiang Xiao, Rongjuan Dai, Jing Ma, Xing Gong
Publikováno v:
Oncotarget
The HBx protein of hepatitis B virus (HBV) is widely recognized to be a critical oncoprotein contributing to the development of HBV-related hepatocellular carcinoma (HCC). In addition, cationic amino acid transporter 1 (CAT-1) gene is a target of miR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dedbaffe3dc697bce532ffb17ad4c94
https://doi.org/10.18632/oncotarget.17631
https://doi.org/10.18632/oncotarget.17631
Publikováno v:
Virus genes. 52(1)
Hepatitis C virus (HCV) infection is a major global health issue. Although the search for HCV treatments has resulted in great achievements, the current treatment methods have limitations, and new methods and drugs for hepatitis C treatment are still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b83d711d27b8a31a27a46f8343358be
https://pubmed.ncbi.nlm.nih.gov/26739460
https://pubmed.ncbi.nlm.nih.gov/26739460